TABLE 1.
Basal (hospitalisation) characteristics of the 45 patients with acute and 6-month follow-up
| n (%) | Median (IQR) | |
|---|---|---|
| Age, years | 45 | 71.50 (64.50–78.00) |
| Sex, male | 29 (64.4) | |
| Medical history | ||
| Previous history of CP disease | 28 (62.2) | |
| Active smokers | 4 (8.9) | |
| Previous smokers | 10 (22.2) | |
| Hypertension | 29 (64.4) | |
| Diabetes | 14 (31.1) | |
| Dyslipidaemia | 20 (44.4) | |
| Atrial fibrillation | 17 (37.8) | |
| Arrythmia | 4 (8.9) | |
| Ischaemic cardiomyopathy | 15 (33.3) | |
| Previous myocardial infarction | 12 (26.7) | |
| Heart failure | 8 (17.8) | |
| Valvulopathy | 6 (13.3) | |
| Stroke | 2 (4.4) | |
| Previous CV hospitalisations | 17 (37.8) | |
| COPD | 4 (8.9) | |
| Hospitalisation data | ||
| Hospitalisation length, days | 45 | 10.00 (5.75–16.00) |
| Intensive care | 5 (11.1) | |
| Deaths during hospitalisation | 0 (0) | |
| Need of any oxygen therapy | 26 (58) | |
| Highest level of O2 support | ||
| O2 low flow | 13 (28.9) | |
| CPAP | 12 (26.7) | |
| Venturi | 0 (0) | |
| Intubation | 1 (2.2) | |
| CT lung involvement, % | 43 | 11.23 (7.51–18.43) |
| hsTnI at admission, ng·L−1 | 32 | 20.80 (6.25–64.54) |
| hsTnI highest, ng·L−1 | 28 | 65.00 (15.01–1694.32) |
| BNP, pg·mL−1 | 42 | 243 (74.00–379.00) |
| CRP at admission, mg·L−1 | 45 | 23.30 (9.05–52.85) |
| CRP highest, mg·L−1 | 45 | 53.95 (25.20–139.45) |
| Leukocytes, 103·μL−1 | 45 | 7.40 (5.85–9.53) |
| Leukocytes highest, 103·μL−1 | 45 | 10.30 (8.28–13.93) |
| ST2, ng·mL−1 | 25 | 70.80 (38.55–100.55) |
| D-dimer peak, ng·mL−1 | 39 | 821.21 (575.45–1411.18) |
Data are presented as n (%) or median (interquartile range (IQR)). CP: cardiopulmonary; CV: cardiovascular; CPAP: continuous positive airway pressure; CT: computed tomography; hsTnI: high sensitive troponin-I; BNP: B-type natriuretic peptide; CRP: C-reactive protein; ST2: soluble interleukin 1 receptor-like 1.